Fusion Pharmaceuticals Inc (FUSN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
21.55 +0.03 (+0.14%) 06/03/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 21.55 unch (unch) -
for Mon, Jun 3rd, 2024
Results
download Want to compare other data? Select Fields| Symbol | FUSN | NAMS | CNTA | ||
| Company | Fusion Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.55 | 17.80 | 13.68 | ||
| High | 21.59 | 18.62 | 14.00 | ||
| Low | 21.45 | 17.43 | 13.47 | ||
| Last | 21.55 | 18.55 | 13.72 | ||
| Change | +0.03 | +0.72 | -0.03 | ||
| % Change | +0.14% | +4.04% | -0.22% | ||
| Volume | 6,089,100 | 424,000 | 483,400 | ||
| 20-Day Average Volume | 945,620 | 932,940 | 992,735 | ||
| Previous Close | 21.52 | 17.83 | 13.75 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 21.47 | 16.69 | 12.45 | ||
| 20-Day Raw Stochastic | 80.00% | 70.27% | 86.92% | ||
| 20-Day Relative Strength | 72.24% | 48.96% | 49.17% | ||
| Weighted Alpha | +82.32 | -25.30 | +25.86 | ||
| Today's Opinion | 100% Buy | 72% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.33% since 05/24/24 | +10.48% since 04/22/25 | +8.29% since 04/22/25 | ||
| Low | 21.38 on 05/30/24 | 16.75 on 04/23/25 | 12.85 on 04/23/25 | ||
| High | 21.60 on 05/31/24 | 18.62 on 04/29/25 | 14.08 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +0.47% since 05/03/24 | -14.75% since 03/28/25 | -5.96% since 03/28/25 | ||
| Low | 21.35 on 05/10/24 | 14.06 on 04/07/25 | 9.60 on 04/09/25 | ||
| High | 21.60 on 05/31/24 | 22.06 on 03/31/25 | 14.89 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +79.73% since 03/01/24 | -10.73% since 01/29/25 | -19.10% since 01/29/25 | ||
| Low | 9.09 on 03/14/24 | 14.06 on 04/07/25 | 9.60 on 04/09/25 | ||
| High | 21.60 on 05/31/24 | 24.51 on 03/24/25 | 19.09 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | +302.80% since 12/01/23 | -2.21% since 10/29/24 | -11.14% since 10/29/24 | ||
| Low | 4.78 on 12/11/23 | 14.06 on 04/07/25 | 9.60 on 04/09/25 | ||
| High | 21.60 on 05/31/24 | 27.29 on 12/11/24 | 19.09 on 02/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,833,043 | 1,958,055 | 1,831,280 | ||
| Shares Outstanding, K | 85,060 | 109,818 | 133,184 | ||
| Annual Sales | 2,070,000 | 45,560,000 | 0 | ||
| Annual Net Income | -94,900,000 | -241,600,000 | -235,760,000 | ||
| Last Quarter Sales | 0 | 12,770,000 | 0 | ||
| Last Quarter Net Income | -28,180,000 | -92,180,000 | -111,330,000 | ||
| 60-Month Beta | -0.69 | -0.01 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.40 on 05/07/24 | -0.95 on 02/26/25 | -0.34 on 03/24/25 | ||
| Latest Earnings Date | 05/09/24 | 05/14/25 | 05/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||